BiotechTube
Home/MediciNova/Yuichi Iwaki
YI

Yuichi Iwaki

President, Chief Executive Officer, and Founder

MediciNova

Therapeutic Areas

NeurologyRespiratoryFibrotic Diseases

MediciNova Pipeline

DrugIndicationPhase
MN-166 (ibudilast)Progressive Multiple SclerosisPhase 3
MN-221 (bedoradrine)Acute Exacerbations of AsthmaPhase 3
MN-001 (tipelukast)Liver Fibrosis (NASH)Phase 2

Leadership Team at MediciNova

KM
Kazuko Matsuda
Chief Medical Officer
DH
David H. Crean
Chief Business Officer
JJ
Jason J. Kruger
Chief Financial Officer
View full MediciNova profile